| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/29/2004 | EP1461443A2 Carbohydrate-associated proteins |
| 09/29/2004 | EP1461441A1 Flavivirus vaccine delivery system |
| 09/29/2004 | EP1461436A1 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| 09/29/2004 | EP1461427A2 Methods for targeted expression of therapeutic nucleic acid |
| 09/29/2004 | EP1461422A1 Interleukin-2 gene transferred lymphokine activated killer cells |
| 09/29/2004 | EP1461369A2 Block copolymers |
| 09/29/2004 | EP1461360A2 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 09/29/2004 | EP1461359A2 Novel anti-igf-ir antibodies and uses thereof |
| 09/29/2004 | EP1461358A1 Ifnar2 muteins, their production and use |
| 09/29/2004 | EP1461356A2 Hexa-, hepta-, and octapeptides having antiangiogenic activity |
| 09/29/2004 | EP1461347A1 2-o-(-d-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 09/29/2004 | EP1461340A2 Trioxane derivatives as antimalaria or anticancer compounds |
| 09/29/2004 | EP1461334A2 Pyrazole derived kinase inhibitors |
| 09/29/2004 | EP1461326A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 09/29/2004 | EP1461321A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 09/29/2004 | EP1461313A1 Human adam-10 inhibitors |
| 09/29/2004 | EP1461165A1 Metallic structures incorporating bioactive materials and methods for creating the same |
| 09/29/2004 | EP1461122A2 Treatment of genitourinary tract disorders |
| 09/29/2004 | EP1461092A1 Process for coating a surface of a stent |
| 09/29/2004 | EP1461084A2 Guanidinium transport reagents and conjugates |
| 09/29/2004 | EP1461083A1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 09/29/2004 | EP1461082A2 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen |
| 09/29/2004 | EP1461073A2 Peptide agonists of prostate-specific antigen, and uses therefor |
| 09/29/2004 | EP1461067A1 Compositions and method for treating hepatitis virus infection |
| 09/29/2004 | EP1461063A2 Treatment of glioblastoma with thymosin-alpha 1 |
| 09/29/2004 | EP1461056A2 Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions |
| 09/29/2004 | EP1461054A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 09/29/2004 | EP1461044A1 Pharmaceutical compositions comprising active vitamin d compounds |
| 09/29/2004 | EP1461043A1 Oral pharmaceutical products containing 17 beta-estradiol-3 lower alkanoate, method of administering the same and process of preparation |
| 09/29/2004 | EP1461038A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 09/29/2004 | EP1461033A2 Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 09/29/2004 | EP1461029A1 Taxane based compositions and methods of use |
| 09/29/2004 | EP1461027A1 Treatment of neoplasia |
| 09/29/2004 | EP1461023A2 Prospective identification and characterization of breast cancer stem cells |
| 09/29/2004 | EP1461019A2 Bioadhesive drug delivery system with enhanced gastric retention |
| 09/29/2004 | EP1461001A2 Cancer-associated epitope |
| 09/29/2004 | EP1460999A2 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof |
| 09/29/2004 | EP1460995A1 Transdermal transport of compounds |
| 09/29/2004 | EP1385874A4 Alpha conotoxin peptides with analgesic properties |
| 09/29/2004 | EP1351941B1 Bisaryl derivatives having fsh receptor modulatory activity |
| 09/29/2004 | EP1303527B1 Matrix metalloproteinase inhibitors |
| 09/29/2004 | EP1299350B1 Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness |
| 09/29/2004 | EP1287001B1 Thiophene derivatives useful as anticancer agents |
| 09/29/2004 | EP1276493B1 Cxcr4 agonist treatment of hematopoietic cells |
| 09/29/2004 | EP1254143B1 Lipid-based drug delivery systems |
| 09/29/2004 | EP1244462B1 Pharmaceutical composition comprised of spider venoms, the production thereof, and its use for treating tumor diseases |
| 09/29/2004 | EP1206267B1 Medicaments containing xenogenic oligo- or/and polyribonucleotides |
| 09/29/2004 | EP1192162B1 Taxane derivatives and processes for the preparation thereof |
| 09/29/2004 | EP1169302B1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists |
| 09/29/2004 | EP1153015B1 Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
| 09/29/2004 | EP1144412B1 Immunosuppressive effects of pteridine derivatives |
| 09/29/2004 | EP1140980B1 Pseudopeptide compounds having an inhibiting activity with respect to paths activated by proteins with active tyrosine kinase activity and pharmaceutical compositions containing same |
| 09/29/2004 | EP1123295B1 Bicyclic nitrogen heterocycles |
| 09/29/2004 | EP1059913B1 Emulsion preconcentrates containing cyclosporin or a macrolide |
| 09/29/2004 | EP1019040B1 Aryl ureas for the treatment of inflammatory or immunomodulatory diseases |
| 09/29/2004 | EP1015012A4 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
| 09/29/2004 | EP0993439B1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 09/29/2004 | EP0989999B1 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 09/29/2004 | EP0912196B1 Use of a thexaphyrin in the preparation of a medicament for use with a chemotherapeutic agent in cancer chemosensitization |
| 09/29/2004 | CN1533399A 免疫调节肽 Immunomodulatory peptides |
| 09/29/2004 | CN1533391A Tricyclic compounds and their uses |
| 09/29/2004 | CN1533387A 1-phenysulfonyl-1,3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/29/2004 | CN1533381A Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 09/29/2004 | CN1533293A Combinations comprising epothilones and pharmaceutical uses thereof |
| 09/29/2004 | CN1533285A Adjuvant combination formulations |
| 09/29/2004 | CN1533284A Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 09/29/2004 | CN1533276A Use of thiazole derivatives for preparing medicine for protecting mitochondria |
| 09/29/2004 | CN1533273A Metronomic dosing of taxanes |
| 09/29/2004 | CN1532292A Transcription active test |
| 09/29/2004 | CN1532289A Method for preparing N-end acetylation modified thymosin alpha with recombined E. coli |
| 09/29/2004 | CN1532281A RFecombination of carcino-emhyyonic antigen gene fragment and gene vaccine |
| 09/29/2004 | CN1532202A ANtisense oligonucleotides of targeting human cell death inhibiting protein family member survival protein mRNA, medicinal composition containing them and its use for treating cancer |
| 09/29/2004 | CN1531972A Method for treating tumor |
| 09/29/2004 | CN1531958A Medicine for treating cirrhosis, liver ascites and liver cancer and preparing method |
| 09/29/2004 | CN1531937A Special preparation for treating cancer recovery by mineral spring medicinal bath |
| 09/29/2004 | CN1168741C Monoclonal antibody anti alpha; V-integrin and it use to inhibit alpha; beta; 6-integrain attachment to fibronectine |
| 09/29/2004 | CN1168739C Narcissus seed glycopeptide and its application |
| 09/29/2004 | CN1168738C Biotin derivatives |
| 09/29/2004 | CN1168735C New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
| 09/29/2004 | CN1168733C Novel prodrugs for therapy of tumors and inflammatory disorders |
| 09/29/2004 | CN1168727C Substituted benzimidazole |
| 09/29/2004 | CN1168726C Novel vitamin D analogues |
| 09/29/2004 | CN1168721C 5-cyano-2-aminopyrimidine derivatives |
| 09/29/2004 | CN1168720C Aryl alkanoylpyridazines compounds |
| 09/29/2004 | CN1168709C Alpha-hydroxy, amino and fluoro derivatives of beta-sulphenyl hdyroxamic acids matrix metalloproteinase inhibitors |
| 09/29/2004 | CN1168702C Acyl dipeoptides, prepn method and pharmaceutical compsns. contg. same |
| 09/29/2004 | CN1168693C Substituted phenols and thiophenols useful as antioxidant agents |
| 09/29/2004 | CN1168497C Leptin as an inhibitor of tumor cell proliferation |
| 09/29/2004 | CN1168495C Modified tumor necrosis factor |
| 09/29/2004 | CN1168484C Medicine for treating leukopenia caused by carcinosis radiotherapy and chemotherapy and its preparing method |
| 09/29/2004 | CN1168457C Xiangshen injection and preparation process and use thereof |
| 09/29/2004 | CN1168452C Use of methoxymorpholino dexorubicin for treatment of liver tumor |
| 09/29/2004 | CN1168448C Medicament for preventing and/or treating a memmary carcinoma, containing a steroidal aromatase inhibitor |
| 09/28/2004 | US6797823 Quinoline derivatives and quinazoline derivatives |
| 09/28/2004 | US6797807 Compounds and methods for cancer therapy |
| 09/28/2004 | US6797725 Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 09/28/2004 | US6797721 Contacting the cancer cell with a phorboxazole derivative to inhibit growth of cancer cells, induction of apoptosis and inhibition of metastises |
| 09/28/2004 | US6797718 Ether substituted imidazopyridines |
| 09/28/2004 | US6797716 Imidazonaphthyridines |
| 09/28/2004 | US6797702 Methods and compositions comprising DNA damaging agents and P53 |